This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. The Centers for Disease Control and Prevention’s Advisory Committee on ...
The World Health Organization has approved a second cervical cancer vaccine, this one made by GlaxoSmithKline, meaning U.N. agencies and partners can now officially buy millions of doses of the ...
GlaxoSmithKline's (GSK) cervical cancer vaccine, Cervarix, was today confirmed by the Netherlands Vaccine Institute (NVI) as the cervical cancer vaccine for the Dutch National Immunisation Programme ...
Believed by experts to be important for cervical cancer prevention GRAZ, Austria, May 14 GRAZ, Austria, May 14 -- New data from an extended follow-up study show that GlaxoSmithKline (NYSE: GSK) ...
The FDA has approved Cervarix (human papillomavirus bivalent [types 16 and 18] vaccine, recombinant, from GlaxoSmithKline) for the prevention of cervical pre-cancers and cervical cancer associated ...
A European Medicines Agency (EMA) expert committee has issued a positive opinion of GlaxoSmithKline’s Cervarix. The EMA panel’s positive conclusion was based on data from clinical trials of Cervarix ...
WASHINGTON – Federal health officials said Wednesday a long-delayed vaccine from GlaxoSmithKline successfully blocks the leading virus that causes cervical cancer in women. The Food and Drug ...
NEW YORK, Nov 12 (Reuters) - GlaxoSmithKline Plc's cervical cancer vaccine Cervarix should eventually secure a 50 percent market share, despite being second to market, the group's chief executive said ...
December 3, 2009 — The Cervarix vaccine, manufactured by GlaxoSmithKline, provides a high level of long-term protection against human papillomavirus (HPV) types 16 and 18. According to new data ...
MISSISSAUGA, ON, Oct. 25 /CNW/ - Today, GlaxoSmithKline Inc. (Canada), announced its plan to reduce the cost of CERVARIX TM by 30%. The cost reduction is in response to recent research that ...
WASHINGTON (Reuters) - GlaxoSmithKline Plc's bid to sell its Cervarix cervical cancer vaccine in the United States faced further delay on Tuesday and the company recalled a batch of the vaccine in ...
Oct. 17 -- FRIDAY, Oct. 16 (HealthDay News) -- GlaxoSmithKline's Cervarix vaccine has been approved by the U.S. Food and Drug Administration to prevent the leading cause of cervical cancer, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results